This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
CYCLOPHOSPHAMIDE — Description, Dosage, Side Effects | PillsCard
Rx
CYCLOPHOSPHAMIDE
100 mg/ml, Koncentrat do sporządzania roztworu do wstrzykiwań / do infuzji
INN: Cyclophosphamidum
Data updated: 2026-04-13
Available in:
🇨🇿🇩🇪🇬🇧🇫🇷🇵🇱🇸🇰🇺🇦
Form
Koncentrat do sporządzania roztworu do wstrzykiwań / do infuzji
Dosage
100 mg/ml
Route
dożylnie
Storage
Storage Conditions Store vials at or below 25°C (77°F). During transport or storage of cyclophosphamide vials, temperature influences can lead to melting of the active ingredient, cyclophosphamide [see Dosage and Administration ( 2.4 )] . Discard unused portion. Cyclophosphamide is a hazardous product. Follow special handling and disposal procedures. 1 Sterile, Nonpyrogenic, Preservative-free. The container closure is not made with natural rubber latex.
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
11 DESCRIPTION Cyclophosphamide is an alkylating drug. It is an antineoplastic drug chemically related to the nitrogen mustards. The chemical name for cyclophosphamide is 2-[bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide monohydrate, and has the following structural formula: Cyclophosphamide has a molecular formula of C 7 H 15 Cl 2 N 2 O 2 P•H 2 O and a molecular weight of 279.1. Cyclophosphamide is soluble in water, saline, or ethanol. Cyclophosphamide for Injection, USP is a sterile white cake available as 500 mg, 1 g and 2 g strength single dose vials. 500 mg vial contains 534.5 mg cyclophosphamide monohydrate equivalent to 500 mg cyclophosphamide and 375 mg mannitol 1 g vial contains 1069 mg cyclophosphamide monohydrate equivalent to 1 g cyclophosphamide and 750 mg mannitol 2 g vial contains 2138 mg cyclophosphamide monohydrate equivalent to 2 g cyclophosphamide and 1500 mg mannitol Cyclophosphamide Monohydrate Structure
⚠️ Warnings
For each 100 mg of cyclophosphamide, 5 ml of solvent must be added for reconstitution.
The choice of diluent for reconstituting Cyclophosphamide containing cyclophosphamide depends on the route of administration to be used.
Direct injection:
If the solution is to be used for direct injection, Cyclophosphamide (containing cyclophosphamide) is reconstituted by adding 0.9% sterile sodium chloride solution.
Infusion:
If the solution is to be used for IV infusion, Cyclophosphamide (containing cyclophosphamide) is reconstituted by adding sterile water for injection or 0.9% sterile sodium chloride solution.
The following quantities of water for injections or sodium chloride 0.9 % are added to the vials containing Cyclophosphamide, Powder for Solution for Injection or Infusion
Vial of 500 mg: 25 ml
Vial of 1000 mg: 50 ml
Vial of 2000 mg: 100 ml
Injecting the solvent into the vial for injection creates an abnormally high pressure, which disappears as soon as the second sterile needle has been inserted in the rubber stop of the vial for injection. The powder easily dissolves when the vial for injection is shaken vigorously to produce a clear solution. If the powder does not immediately dissolve, continue to shake the vial vigorously for up to several minutes until complete dissolution of the powder. The solution must be administered as soon as possible following its reconstitution.
After reconstitution the solution is clear and colourless to light yellow. Please check the vial before further use. Only clear solutions must be used.
Cyclophosphamide, Powder for Solution for Injection or Infusion reconstituted in water for injection has an osmolality of 92 mOsm/kg.
Cyclophosphamide, Powder for Solution for Injection or Infusion reconstituted in 0.9% sodium chloride has an osmolality of 353 mOsm/kg and a pH of 4.6
Intravenous use
Intravenous administration should preferably be conducted as an infusion.
Infusion:
Reconstituted Cyclophosphamide should be further diluted in 5% dextrose or 0.9% sodium chloride injection prior to infusion.
Direct injection:
Please note that only Cyclophosphamide reconstituted in 0.9% sterile sodium chloride solution is suitable for bolus injection.
Cyclophosphamide (containing cyclophosphamide) reconstituted in water is hypotonic and should not be injected directly.
The rules and regulations for handling cytostatics in general must be observed when reconstituting or handling Cyclophosphamide. Reconstitution must, to the extent possible, be performed in a
laminar air flow safety
cabinet. The person handling the product must wear a protective mask and protective
gloves
. In case of spills, the area must be thoroughly rinsed with water. If Cyclophosphamide, Powder for Solution for Injection or Infusion is stored (e.g. during transport) at the temperature exceeding the maximum temperature, cyclophosphamide may melt. Vials for injections containing melted cyclophosphamide can be visually recognised. Cyclophosphamide is a white powder. M
elted cyclophosphamide
is a
clear or
yellowish viscous liquid (usually found as droplets in the affected vials.). Vials for injections containing melted cyclophosphamide may no longer be used.